Mr. James A. H. Harwick

Biography

 Mr. James A. H. Harwick, Jin Co-founded TriLogic Pharma, LLC. in 2000 and serves as its Chief Executive Officer. Prior to forming TriLogic Pharma, LLC, Mr. Harwick co-founded Kowa Pharmaceuticals America, Inc. (Formerly, ProEthic Laboratories, LLC.). of Montgomery, Alabama in 2002. During his tenure at Kowa Pharmaceuticals America, Inc., Mr. Harwick held several positions including Senior Vice President of Finance, Chief Financial Officer and Co-President of Midlothian Laboratories (a wholly owned subsidiary). Mr. Harwick served as Co-President of Midlothian Laboratories LLC since June 2005. Mr. Harwick was primarily responsible for the capital formation of ProEthic and raised more than $11 million through three different private placements with "friends and family." Mr. Harwick successfully negotiated ProEthic's in-licensing of its flagship diclofenac franchise, as well as the successful sale of its Ketoprofen TDS Patch asset to Endo Pharmaceuticals Holdings, Inc. for more than $24 million. Prior to joining ProEthic, Mr. Harwick served as an investment officer with three major brokerage firms from 1992 until January of 2002 including First Union Securities. He began his career at A.G. Edwards and Sons, where he excelled in performance by exceeding all productivity goals.

Research Interest

 He is the CEO of the company and a business man